Notably, Mookherjee et al. [1] detailed the mechanisms of action of AMPs against infection both by direct bacterial destruction and by modulation of the host’s immune response, and touched upon the clinical potential of these AMP-based therapies. The gene discussed is ADSL; the disease is infection.